In a recent case report, a patient with refractory seizure, in the setting of testicular cancer and anti-Ma-2 antibodies, showed no evidence of memory decline or psychiatric symptoms prior to presentation [13]. This evidence concerns the gene PNMA2 and testicular cancer.